Articles
Volume 11 Supplement 1
5th International Conference on cGMP: Generators, Effectors and Therapeutic Implications
Meeting abstracts
5th International Conference on cGMP: Generators, Effectors and Therapeutic Implications
Halle, Germany
24-26 June 2011
Edited by John Burnett Jr, Franz Hofmann, Harald HHW Schmidt and Johannes-Peter Stasch
|
Designer natriuretic peptides for heart failure: advanced in clinical development John Burnett BMC Pharmacology 2011, 11(Suppl 1):O1 (1 August 2011) |
|
New clinical results with sGC stimulators Jürgen Behr BMC Pharmacology 2011, 11(Suppl 1):O2 (1 August 2011) |
|
Martin P Lefkowitz BMC Pharmacology 2011, 11(Suppl 1):O3 (1 August 2011) |
|
Biomarkers in kidney and heart disease Alan S Maisel BMC Pharmacology 2011, 11(Suppl 1):O4 (1 August 2011) |
|
Human genetics, natriuretic peptides and hypertension Christopher Newton-Cheh BMC Pharmacology 2011, 11(Suppl 1):O5 (1 August 2011) |
|
Benefits of PDE5 inhibition in patients with diastolic heart failure Marco Guazzi BMC Pharmacology 2011, 11(Suppl 1):O6 (1 August 2011) |
|
Marc T Gladwin BMC Pharmacology 2011, 11(Suppl 1):O7 (1 August 2011) |
|
Redox regulation of responses to hypoxia and NO-cGMP signaling in pulmonary vascular pathophysiology Michael S Wolin, Boon Neo, Dhara Patel, Raed Alhawaj, Sharath Kandhi, Mansoor Ahmad BMC Pharmacology 2011, 11(Suppl 1):O8 (1 August 2011) |
|
Nitric oxide-independent stimulation of soluble guanylate cyclase attenuates pulmonary fibrosis Oleg V Evgenov, Lin Zou, Ming Zhang, Mari Mino-Kenudson, Eugene J Mark, Emmanuel S Buys, Michael J Raher, Yan Li, Yan Feng, Rosemary C Jones, Johannes-Peter Stasch, Wei Chao BMC Pharmacology 2011, 11(Suppl 1):O9 (1 August 2011) |
|
Molecular aspects of sGC regulation Michael A Marletta, Eric S Underbakke, Nathaniel B Fernhoff BMC Pharmacology 2011, 11(Suppl 1):O10 (1 August 2011) |
|
Structural insights into sGC activation by different activators Focco van den Akker, Faye Martin, Vijay Kumar, Xiaolei Ma, Johannes-Peter Stasch, Martina Schaefer, Padmamalini Baskaran, Annie Beuve, Pete W van Dunten BMC Pharmacology 2011, 11(Suppl 1):O11 (1 August 2011) |
|
PKA: assembly of dynamic macromolecular signaling Susan S Taylor, Ronit Ilouz, Manjula Darshi, Ganapathy Sarma, Alexandr Kornev, Ping Zhang BMC Pharmacology 2011, 11(Suppl 1):O12 (1 August 2011) |
|
Crystal structure of cGMP-dependent protein kinase reveals novel site of interchain communication Wolfgang R Dostmann, Brent W Osborne BMC Pharmacology 2011, 11(Suppl 1):O13 (1 August 2011) |
|
Jeong Kim, Darren E Casteel, Gilbert Huang, Taek Kwon, Ronnie Ren, Peter Zwart, Jeffrey J Headd, Nicholas Brown, Dar-Chone Chow, Timothy Palzkill, Choel Kim BMC Pharmacology 2011, 11(Suppl 1):O14 (1 August 2011) |
|
Carmen Methner, Robert Lukowski, Franz Hofmann, Michael Murphy, Thomas Krieg BMC Pharmacology 2011, 11(Suppl 1):O15 (1 August 2011) |
|
Effects of long-term proBNP cardiac gene delivery in experimental hypertensive heart disease Alessandro Cataliotti, Jason M Tonne, Guido Boerrigter, Salvatore Mangiafico, John C Burnett, Yasuhiro Ikeda BMC Pharmacology 2011, 11(Suppl 1):O16 (1 August 2011) |
|
Vascular and renal function of cGMP signalling Jens Schlossmann, Elisabeth Schinner, Matthias Desch, Bernhard Hieke, Petra Rothammer, Katharina Salb, Andrea Schramm BMC Pharmacology 2011, 11(Suppl 1):O17 (1 August 2011) |
|
Eiki Takimoto BMC Pharmacology 2011, 11(Suppl 1):O18 (1 August 2011) |
|
cGMP kinase I, cardiac hypertrophy and PDE inhibition Enrico Patrucco, Robert Lukowski, Sergei Rybalkin, Joe Beavo, Franz Hofmann BMC Pharmacology 2011, 11(Suppl 1):O19 (1 August 2011) |
|
Molecular targets for PDE inhibitor-mediated improvement of cardiac dysfunction in the mdx mouse? Candace M Adamo, Dao-Fu Dai, Justin M Percival, Elina Minami, Monte S Willis, Enrico Patrucco, Sergei D Rybalkin, Stanley C Froehner, Joseph A Beavo BMC Pharmacology 2011, 11(Suppl 1):O20 (1 August 2011) |

